Add BrightSurf on Google Email

Michigan Medicine - University of Michigan


Existing drugs kill SARS-CoV2 in cells

Researchers have identified several drug contenders that can block or reduce SARS-CoV2 infection in cells, including lactoferrin and MEK-inhibitors. These findings suggest potential efficacy against COVID-19 variants, with ongoing clinical trials to examine their ability to reduce viral loads and inflammation.

SourceMichigan Medicine - University of Michigan·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateAug 19, 2021

Short hospitalizations hit hard for COVID patients

A US nationwide cohort study found that nearly 85% of hospitalized COVID-19 patients were not back to their pre-COVID lives one month later. The study also revealed significant factors driving people's inability to recover, including a lack of follow-up healthcare services and new disabilities preventing daily activities.

SourceMichigan Medicine - University of Michigan·JournalJournal of Hospital Medicine·TypeObservational study·DateAug 18, 2021

Pumping iron: Inhibition of key pathway promotes iron-dependent cell death in pancreatic cancer cells

Researchers have discovered that inhibiting the GOT1 enzyme can promote ferroptosis, a type of programmed cell death, in pancreatic cancer cells by conserving nutrients and releasing iron stores. This study provides a new potential therapeutic target for treating pancreatic cancer.

SourceMichigan Medicine - University of Michigan·JournalNature Communications·TypeExperimental study·DateAug 11, 2021

Potential biomarker found for lung disease in scleroderma patients

Researchers discovered a protein called CTRP9 associated with pulmonary function in scleroderma patients with interstitial lung disease. Patients with higher CTRP9 levels developed more severe lung disease, while low levels were linked to preserved function. The study suggests CTRP9 could help predict treatment needs for these patients.

SourceMichigan Medicine - University of Michigan·TypeData/statistical analysis·DateAug 3, 2021

Researchers uncover a way to harness the power of immunotherapy for advanced prostate cancer

Researchers have found a way to harness the power of immunotherapy for advanced prostate cancer by targeting a protein called PIKfyve. Blocking PIKfyve with the inhibitor ESK981 has been shown to increase tumor death and recruit immune T cells, offering new hope for patients with this challenging form of cancer.

SourceMichigan Medicine - University of Michigan·JournalNature Cancer·TypeExperimental study·DateAug 2, 2021

Study suggests need to screen older adults for mental health symptoms as pandemic continues

A new study suggests that older adults, particularly women and those in fair or poor health, are more likely to experience worsened mental health symptoms during the pandemic. The study recommends screening for depression, anxiety, and sleep problems and connecting participants to treatment resources.

SourceMichigan Medicine - University of Michigan·JournalJournal of General Internal Medicine·TypeSurvey·DateJul 28, 2021

Genomic test could help predict aggressive disease in men newly diagnosed with prostate cancer

A new genomic test may help identify patients at high risk of prostate cancer progression. The Decipher Biopsy test showed that men with high scores needed active treatment sooner, and those who underwent surgery had shorter time until PSA levels increased or they were put on anti-androgen therapy.

SourceMichigan Medicine - University of Michigan·JournalProstate Cancer and Prostatic Diseases·DateJul 27, 2021

Online mental health therapy significantly aids the isolated, immunosuppressed in pandemic

Researchers found that online mental health intervention improved anxiety and depression in people with scleroderma, a disease causing skin and connective tissue tightening. The four-week program offered group mental health intervention from trained peer support leaders, resulting in significant improvements six weeks later.

SourceMichigan Medicine - University of Michigan·JournalThe Lancet Rheumatology·DateJun 16, 2021

Older adults with cerebral palsy need more, receive less physical therapy

A recent study found that adults with cerebral palsy receive significantly less physical therapy for musculoskeletal disorders, despite greater risk of secondary comorbid conditions. The researchers underscore the need for increased clinical awareness and improved screening strategies to address this inequity in healthcare.

SourceMichigan Medicine - University of Michigan·JournalDisability and Health Journal·DateMay 28, 2021

Physician-patient gender concordance may not matter in interventional practice

A study by Michigan Medicine found that female interventional cardiologists have comparable outcomes to their male counterparts in coronary angioplasties. Despite being significantly under-represented, they demonstrate excellent practitioner skills. The findings suggest benefits for female trainees considering the field.

SourceMichigan Medicine - University of Michigan·JournalCatheterization and Cardiovascular Interventions·DateMay 25, 2021

Gout treatment success doubled by combining two drugs, study finds

A recent study found that combining two medications can double the effectiveness of gout treatment. Researchers at Michigan Medicine discovered that adding immunomodulation drug mycophenolate mofetil to Pegloticase infusions significantly increased the success rate, reducing urate levels below the therapeutic target in 86% of patients.

SourceMichigan Medicine - University of Michigan·JournalArthritis & Rheumatology·DateMay 11, 2021